personalized medicine
Avalon GloboCare, Lu Daopei Hematology Institute Partner to Develop Cell Therapy CDx
The deal, which is subject to negotiation, will help Avalon create diagnostics for personalizing its current and future cell immunotherapy programs.
Guidelines Update Supports Use of Genomic Tests in Early Prostate Cancer Management
Although authors cautioned against routine testing, they wrote that clinicians may consider genomic testing in cases where it might change their clinical decisions.
Tempus to Provide NGS Cancer Tests to US Department of Veterans Affairs
VA healthcare providers will be able to access Tempus' suite of next-generation sequencing-based cancer tests under a multiyear deal.
NGeneBio Receives CE-IVD Mark for NGS-Based Cancer Panel
The firm's accompanying software analyzes companion diagnostic biomarkers such as EGFR, BRAF, KRAS, HER2, and ROS1 genes.
Brain Cancer Canada Funds Development of New Dx Sequencing Assay at St. Michael's Hospital
The group plans to develop and implement a custom gene sequencing assay intended to help rapidly diagnose brain cancers and inform molecularly targeted treatment.